跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
CIMA-AEMPS
/
OBGEMSA 75 MG COMPRIMIDOS RECUBIERTOS CON PELICULA
Approved
STANDARD
OBGEMSA 75 MG COMPRIMIDOS RECUBIERTOS CON PELICULA
Pierre Fabre Medicament
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Jul 30, 2024
Approval ID
7ac3f48a8344a67d
Company
Pierre Fabre Medicament
Type
Standard
Approval Details
Approval Id
7ac3f48a8344a67d
Drug Cima Aemps Name
OBGEMSA 75 MG COMPRIMIDOS RECUBIERTOS CON PELICULA
Register Number
1241822001
Holder Company Name
Pierre Fabre Medicament
Marketing Company Name
Pierre Fabre Iberica S.A.
Holder Company Detail Path
/organization/pierre-fabre-medicament
Authorization Date
2024-07-30
Dosage Form
COMPRIMIDO RECUBIERTO CON PELÍCULA
Dose
75 mg
Route Of Administration
VÍA ORAL
Prescription Type
Medicamento Sujeto A Prescripción Médica
Commercialized
Yes
Company Name
Pierre Fabre Medicament
Company Detail Path
/organization/pierre-fabre-medicament
Company Information
Pharmaceutical Company Name
PIERRE FABRE MEDICAMENT
Country Name
India
City Name
mumbai,maharashtra,country_in
Address
P2, 3RD FLOOR, RAGHUVANSHI MILLS COMPOUND 11/12
Active Ingredients
VIBEGRON
75 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Jul 30, 2024
Approval ID
7ac3f48a8344a67d
Type
Standard
Back to CIMA-AEMPS Approvals
OBGEMSA 75 MG COMPRIMIDOS RECUBIERTOS CON PELICULA - CIMA-AEMPS Drug Approval Details
